A FAMILY Program for Childhood Overweight and Obesity

Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03773250
Collaborator
(none)
164
1
2
36
4.6

Study Details

Study Description

Brief Summary

Childhood overweight and obesity is a health problem with lifelong implications related to diabetes, hypertension, cardiovascular disease, psychological disorders as well as other chronic conditions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral intervention
N/A

Detailed Description

In Taiwan, the nationwide prevalence of overweight and obesity among school-age children aged 7 to 11 years has also increased over the past years. Sleep and weight are intricately related. School-age children requires at least 10 hours of sleep per night but children in Asian countries are on average obtaining shorter sleep than children in Caucasian countries.

Study Design

Study Type:
Interventional
Actual Enrollment :
164 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
A FAMILY Program for Childhood Overweight and Obesity
Actual Study Start Date :
Aug 1, 2018
Actual Primary Completion Date :
Jul 31, 2021
Actual Study Completion Date :
Jul 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral Intervention

Children and families in the intervention group will received the FAMILY program developed according to evidence-based guidelines.The intervention content regarding healthy sleep will emphasize the importance of having a consistent sleep schedule, establishing a regular bedtime routine, and creating an environment only for sleeping. The physical activity content will emphasize at least 60 minutes/day of moderate-to-vigorous intensity physical activity, reduction of sedentary behavior, and screen time limited to 2 hours/day. The nutrition content will emphasis the replacement of sugar-sweetened beverages, increased fruit and vegetable as well as water intake, consumption of regular meals, and reduction of discretionary food groups.

Behavioral: Behavioral intervention
The intervention has an intensive phase and a maintenance phase.

Other: Control

An active placebo control intervention was designed which did not apply evidence-based lifestyle recommendations effective in weight loss and focused on vegetable education.

Behavioral: Behavioral intervention
The intervention has an intensive phase and a maintenance phase.

Outcome Measures

Primary Outcome Measures

  1. Child BMI-for-age z-score [Change from baseline to 12 months post intervention]

    Child BMI-for-age z-score will be computed based on the World Health Organization growth reference data for 5-19 years.

Secondary Outcome Measures

  1. Child BMI [Change from baseline to 12 months post intervention]

    Child BMI will be calculated based on child weight and height.

  2. Child percent body fat [Change from baseline to 12 months post intervention]

    Percent body fat will be estimated according to the skinfold thickness equations.

  3. child sleep duration and sleep efficiency [Change from baseline to 12 months post intervention]

    Actigraphy-derived daily sleep duration and nocturnal sleep efficiency

  4. Parental sleep quality [Change from baseline to 12 months post intervention]

    Pittsburgh Sleep Quality Index total scores

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children with overweight and obesity
Exclusion Criteria:
  • Children with any other chronic or acute medical conditions

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Taiwan University Taipei Taiwan

Sponsors and Collaborators

  • National Taiwan University Hospital

Investigators

  • Principal Investigator: Shao-Yu Tsai, PhD, National Taiwan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT03773250
Other Study ID Numbers:
  • 201603121RIND
First Posted:
Dec 12, 2018
Last Update Posted:
Aug 11, 2022
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 11, 2022